Bulletin
Investor Alert

Aptose Biosciences Inc.

NAS: APTO

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200556527/composite

$

5.77

Change

-0.02 -0.35%

Volume

Volume 4,446

Sep 23, 2020, 7:43 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200556527/composite

Today's close

$ 6.25

$ 5.79

Change

-0.46 -7.36%

Day low

Day high

$5.76

$6.29

Open
Open: 6.25

52 week low

52 week high

$1.82

$9.25

Open

Market cap

$546.53M

Average volume

1.07M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.61

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/apto

MarketWatch News on APTO

  1. Aptose Biosciences stock price target raised to $8 from $6 at Oppenheimer

    8:30 a.m. Jan. 17, 2020

    - Tomi Kilgore

  2. Aptose Biosciences maintained as buy at Canaccord

    3:04 p.m. Dec. 10, 2019

    - Ciara Linnane

  3. Aptose Biosciences started at outperform with $6 stock price target at Oppenheimer

    8:54 a.m. Jan. 25, 2019

    - Tomi Kilgore

  4. Aptose says batch had correctable engineering design incompatability in filling process

    9:03 a.m. Dec. 29, 2016

    - Ciara Linnane

  5. Aptose Biosciences says it must repeat production of myeloid leukemia drug for trial

    9:02 a.m. Dec. 29, 2016

    - Ciara Linnane

  6. Aptose Biosciences shares halted in premarket trade

    9:00 a.m. Dec. 29, 2016

    - Ciara Linnane

  7. Aptose’s Cancer Drug to Overcome Issues

    12:02 p.m. Nov. 24, 2015

    - Barron's Online

  8. Aptose Biosciences' stock tumbles 35%, leads Nasdaq losers, after drug dosing suspension

    10:36 a.m. Nov. 20, 2015

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/apto

Other News on APTO

  1. Sector Watch: More oncology events as cancer ETF breaks out

    9:59 a.m. Sept. 20, 2020

    - Seeking Alpha

  2. Aptose Biosciences (APTO) Surges: Stock Moves 9.8% Higher

    8:50 a.m. Sept. 2, 2020

    - Zacks.com

  3. New Strong Sell Stocks for August 28th

    6:53 a.m. Aug. 28, 2020

    - Zacks.com

  4. 10-Q: APTOSE BIOSCIENCES INC.

    5:04 p.m. Aug. 4, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. TCDA, NCLH among premarket losers

    8:16 a.m. July 16, 2020

    - Seeking Alpha

  6. Aptose proposes a public offer

    4:13 p.m. July 15, 2020

    - Seeking Alpha

  7. Aptose's CG-806 shows encouraging effect in blood cancer

    9:05 a.m. June 12, 2020

    - Seeking Alpha

  8. 10-Q: APTOSE BIOSCIENCES INC.

    4:04 p.m. May 5, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. CG-806 data fails to lift Aptose, down 11%

    11:32 a.m. April 27, 2020

    - Seeking Alpha

  10. Aptose Riding Higher As The Street Starts Paying Attention

    12:00 p.m. April 10, 2020

    - Seeking Alpha

  11. 10-K: APTOSE BIOSCIENCES INC.

    5:03 p.m. March 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Loading more headlines...
/news/pressrelease/company/us/apto

Press Releases on APTO

  1. Stocks in Play: Aptose Biosciences Inc.

    10:00 a.m. Sept. 9, 2020

    - Baystreet.ca

  2. Aptose to Present at September Investor Conferences

    7:30 a.m. Sept. 9, 2020

    - GlobeNewswire

  3. Aptose to Present at September Investor Conferences

    7:30 a.m. Sept. 9, 2020

    - GlobeNewswire

  4. Canadian Stocks That Surged Today: $APS $LGO $SIA

    9:24 a.m. Aug. 26, 2020

    - The Market Signal

  5. Bromodomain Containing Protein 4 Market Analysis by Research Report 2020

    6:11 a.m. Aug. 5, 2020

    - Market Insight Reports

  6. Aptose Reports Results for the Second Quarter 2020

    4:03 p.m. Aug. 4, 2020

    - GlobeNewswire

  7. Aptose Reports Results for the Second Quarter 2020

    4:01 p.m. Aug. 4, 2020

    - GlobeNewswire

  8. Aptose Announces Pricing of Public Offering of Common Shares

    10:50 p.m. July 15, 2020

    - GlobeNewswire

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.